First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54%
Updated: May 15, 2024

Clarus Therapeutics Holdings Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clarus Therapeutics Holdings Inc
Total Other Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Total Other Income
$12.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Total Other Income
-$149m
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
-54%
Pfizer Inc
NYSE:PFE
Total Other Income
-$5m
CAGR 3-Years
N/A
CAGR 5-Years
50%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Total Other Income
$1.5B
CAGR 3-Years
48%
CAGR 5-Years
41%
CAGR 10-Years
18%
Eli Lilly and Co
NYSE:LLY
Total Other Income
$456.1m
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
20%

See Also

What is Clarus Therapeutics Holdings Inc's Total Other Income?
Total Other Income
12.5m USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Total Other Income amounts to 12.5m USD.

What is Clarus Therapeutics Holdings Inc's Total Other Income growth rate?
Total Other Income CAGR 1Y
-81%

Over the last year, the Total Other Income growth was -81%.